The Biovac Institute has retained a critical contract to supply the South African state with Hexaxim. Hexaxim is the six-in-one shot provided to infants in the national childhood immunisation programme. The R5.3bn award was announced in the Department of Health’s next three-year national vaccine tender. This tender is set to begin on January 1, 2027. This contract is vital to…